Neoplasmata vesicae felleae et ductuum biliferorum
For medical students2 min readUpdated 2026-10-10
Neoplasms of the biliary system comprise rare benign processes and aggressive malignant tumors of epithelial origin. Due to their insidious course and late presentation, these diseases pose a significant challenge in clinical practice.
Main histologyAdenocarcinoma is diagnosed in the vast majority of cases.
Risk factorUlcerative colitis increases the risk of bile duct cancer 10-fold.
DiagnosisGallbladder cancer often mimics chronic cholecystitis.
Age peakGallbladder cancer — after age 50; bile duct cancer — after age 70.
Benign Neoplasms
Extremely rare. They include:
Epithelial: adenoma.
Mesenchymal: fibroma, lipoma.
Gallbladder Carcinoma
The tumor develops from the mucosal epithelium, most commonly located in the fundus or neck of the gallbladder.
Macroscopy: May appear as papillary projections or diffuse wall thickening visually indistinguishable from chronic inflammation.
Invasion: The tumor rapidly infiltrates the wall and spreads to adjacent organs, primarily the liver.
Histology: Adenocarcinoma predominates. Squamous cell carcinoma, developing against a background of epithelial metaplasia, is less common.
Bile Duct Carcinoma
An epithelial tumor of the bile ducts characterized by slow growth and a tendency to invade surrounding tissues. The primary sites of involvement are the confluence of the hepatic ducts and the distal common bile duct (region of the major duodenal papilla).
Clinically manifests early as extrahepatic jaundice, pain, and weight loss due to the strategic anatomical location of the process.
Mnemonic
Gallbladder is the "silent killer" (mimics cholecystitis); Bile ducts give a "yellow warning" (presents early with jaundice).
Frequently asked questions
What are the pathways of metastasis in gallbladder cancer?
Gallbladder cancer metastasizes via lymphatic and hematogenous routes and is also characterized by local invasive growth.
Key dissemination pathways include:
Lymphatic metastasis — extensive regional involvement of lymph nodes.
Hematogenous metastasis — spread of tumor cells via the bloodstream to distant organs.
Local and vascular invasion — direct extension of the tumor into the gallbladder wall, blood vessels, and adjacent organs (e.g., the liver).
What underlying and precancerous conditions are associated with gallbladder cancer?
Underlying and precancerous conditions for gallbladder cancer include chronic inflammatory processes, benign neoplasms, and hereditary disorders.
Key conditions include:
Cholelithiasis — accompanied by chronic inflammation.
Hyalinizing cholecystitis — involves focal or diffuse calcification ("porcelain gallbladder").
Benign lesions — polyps larger than 1 cm, adenomas, and adenomatosis of the gallbladder.
Hereditary syndromes — hereditary nonpolyposis colorectal cancer (Lynch syndrome).
Which genetic mutations are most characteristic of cholangiocarcinoma?
Cholangiocarcinoma (especially intrahepatic) is characterized by several activating genetic mutations and translocations.
Key genetic alterations include:
KRAS mutations — identified in 23% of cases of the biliary-type intrahepatic cholangiocarcinoma and only in 1% of the cholangiolar type.
NTRK and FGFR1–4 gene translocations — detection is mandatory for targeted molecular therapy.
BRAF/RAS co-mutations — presence significantly reduces the efficacy of targeted treatment (specifically, anti-HER2 therapy).
Why is gallbladder cancer often diagnosed late?
Tumor symptoms are non-specific and closely mimic chronic cholecystitis, hindering early detection.
What is the association between ulcerative colitis and biliary tract tumors?
Ulcerative colitis is a significant risk factor: it increases the risk of bile duct cancer by 10 times and contributes to the development of gallbladder cancer at a younger age (under 40 years).
What morphological growth patterns are characteristic of bile duct carcinoma?
The tumor can grow as a mass (nodular), as papillary projections, or diffusely infiltrate the duct wall.
Go deeper
Differential diagnosis of gallbladder cancer and chronic cholecystitis.
Mechanisms of squamous cell metaplasia of the gallbladder epithelium.
Metastatic patterns in carcinoma of the major duodenal papilla.
Impact of familial adenomatous polyposis on biliary tract oncogenesis.